David A. Leiman

S446 Results from KRYPTOS, a Phase 2/3 Study of Lirentelimab (AK002) in Adults and Adolescents With EoE

Evan S. Dellon, Mirna Chehade, Robert M. Genta et al. · The American Journal of Gastroenterology · 2022 · 48 citations

Life Sciences, Immunology, Pharmacology +17

Survey of gastroenterologistsʼ awareness and implementation of AGA guidelines on osteoporosis in inflammatory bowel disease patients: Are the guidelines being used and what are the barriers to their use?

Julianne Wagnon, David A. Leiman, Gregory D. Ayers et al. · Inflammatory Bowel Diseases · 2009 · 46 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +10

Evaluation of the Potential Utility of an Artificial Intelligence Chatbot in Gastroesophageal Reflux Disease Management

Jacqueline B. Henson, Jeremy R. Glissen Brown, Joshua P. Lee et al. · The American Journal of Gastroenterology · 2023 · 43 citations · Full text

Computing, Computer Science, Health Informatics +15

Difluoromethylornithine Is a Novel Inhibitor of Helicobacter pylori Growth, CagA Translocation, and Interleukin-8 Induction

Daniel P. Barry, Mohammad Asim, David A. Leiman et al. · PLoS ONE · 2011 · 39 citations · Full text

Life Sciences, Microbiology, Pharmacology +15

Inflammatory Bowel Disease Patients’ Willingness to Accept Medication Risk to Avoid Future Disease Relapse

Meenakshi Bewtra, Angelyn Fairchild, Erin Gilroy et al. · The American Journal of Gastroenterology · 2015 · 38 citations · Full text

Medicine, Health Sciences, Internal Medicine +14